Log in

Andrologische Aspekte im Auge haben!

Psoriasis und Partnerschaft

  • Fortbildung
  • Published:
hautnah dermatologie Aims and scope

Lebensqualität und Krankheitsbewältigung werden bei Patienten mit einer Psoriasis vulgaris durch verschiedene Belastungsfaktoren beeinträchtigt. Die allzu oft vernachlässigten sexualmedizinischen Aspekte dieser Erkrankung werden im Folgenden aus andrologischer Sicht beleuchtet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Aguirre MA, Velez A, Romero M, Collantes E. Gynecomastia and sexual impotence associated with methotrexat treatment. J Rheumatol 2002; 29:1793–1794

    PubMed  Google Scholar 

  2. Armstrong AW, Harskamp CT, Schupp CW. Psoriasis and Sexual Behavior in Men: Examination of the National Health and Nutrition Examination Survey (NHANES) in the United States. J Sex Med 2013

  3. Boehncke S, Salgo R, Garbaraviciene J, Beschmann H, Ackermann H, Boehncke WH, Ochsendorf FR. Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study. Arch Dermatol Res 2011; 303(6): 417–24

    Article  CAS  PubMed  Google Scholar 

  4. Chung SD, Keller JJ, Chu TW, Lin HC. Psoriasis and the risk of erectile dysfunction: a population—based case-control study. J Sex Med 2012; 9: 130–135

    Article  PubMed  Google Scholar 

  5. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011; 8(1): 272–83

    Article  CAS  PubMed  Google Scholar 

  6. Enamandram M, Kimball AB. Psoriasis Epidemiology: The Interplay of Genes and the Environment. J Invest Dermatol 2013; 133:287–289

    Article  CAS  PubMed  Google Scholar 

  7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210–216

    Article  CAS  PubMed  Google Scholar 

  8. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53 (4): 573

    Article  PubMed  Google Scholar 

  9. Goulding, JM, Price CL, Defty CL, Hulangamuwa CS, Bader E, Ahmed I. Erectile dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. Br J Dermatol 2011; 164: 103–109

    Article  CAS  PubMed  Google Scholar 

  10. Grunewald S, Paasch U, Glander HJ. Systemische dermatologische Therapie mit Relevanz für die männliche Fertilität. J Dtsch Dermatol Ges 2007; 5(1):15–21

    Article  PubMed  Google Scholar 

  11. Guenther L, Han C, Szapary P, Schenkel B, Poulin Y, Bourcier M, Ortonne JP, Sofen HL. Impact of ustekinumab on health-related quality of life and sexuel difficulties associated with psoriasis: results from two phase III clinical trials. J Eur Acad Dermatol Venereol 2011; 25:851–857

    Article  CAS  PubMed  Google Scholar 

  12. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36: 259–262

    Article  CAS  PubMed  Google Scholar 

  13. Kimball et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 67:76–85

    Article  PubMed  Google Scholar 

  14. Köhn FM, Schuppe HC, Ochsendorf FR Dermatologische Krankheitsbilder hemmen das sexuelle Leben. Gyne 2013; 34: 26–27

    Google Scholar 

  15. Krause WKH (2008) Drugs compromising male sexual health. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  16. Kurizky PS, da Mota LMH. Sexual dysfunction in patients with psoriasis and psoriatic arthritis — a systematic review. Rev Bras Rheumatol 2012; 52: 938–948

    Google Scholar 

  17. Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol. 2011 Apr;147(4):419–24.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Magin P, Heading G, Adams J, Pond D. Sex and the skin: a qualitative study of patients with acne, psoriasis and atopic eczema. Psychol Health Med 2010; 15: 454–462

    Article  PubMed  Google Scholar 

  19. Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, Evers AW, Massuger LF, van de Kerkhof PC, van Rossum MM. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol 2011; 164: 1247–1255

    Article  CAS  PubMed  Google Scholar 

  20. Miner MM. Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability? J Androl. 2011 Mar-Apr;32(2):125–34.

    Article  PubMed  Google Scholar 

  21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143–3421

    Google Scholar 

  22. Niemeier V, Winckelesser T, Gieler U. Hautkrankheit und Sexualität. Hautarzt 1997; 48: 629–633

    Article  CAS  PubMed  Google Scholar 

  23. Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195–201

    Article  CAS  PubMed  Google Scholar 

  24. Reynolds OD. Erectile dysfunction in etretinate treatment. Arch Dermatol 1991;127:425–426.

    Article  CAS  PubMed  Google Scholar 

  25. Rossi M, Pellegrino M. Acitretin-associated erectile dysfunction: a case report. Cases J 2009; 2:210

    Article  PubMed Central  PubMed  Google Scholar 

  26. Ruiz-Villaverde R, Sanchez-Cano D, Rodrigo JR, Gutierrez CV. Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy. Indian J Dermatol 2011; 56:694–699

    Article  PubMed Central  PubMed  Google Scholar 

  27. Sampogna F, Gisondi P, Tabolli S, IDI Multipurpose Psoriasis Research on Vital Experiences Investigators. Dermatology 2007;214:144–150.

    PubMed  Google Scholar 

  28. Saougou I, Markatseli TE, Papagoras C, Kaltsonoudis E, Voulgari PV, Drosos AA. Fertility in male patients with seronegative spondyloarthropathies treated with infliximab. Joint Bone Spine. 2012 May 8. [Epub ahead of print].

  29. Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001; 15: 611–617

    Article  CAS  PubMed  Google Scholar 

  30. Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR (2013). Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol 14: 1–7.

    Article  PubMed  Google Scholar 

  31. Türel Ermertcan A, Temeltas G, Deveci A, Dinc G, Güler HB, Oztürkcan S. Sexual dysfunction in patients with psoriasis. J Dermatol 2006; 33:772–778

    Article  PubMed  Google Scholar 

  32. Van Dorssen IE, Boom BW, Hengeveld MW (1992) Experience of sexuality in patients with psoriasis and constitutional eczema. Ned Tijdschr Geneeskd 136: 2175–2178.

    PubMed  Google Scholar 

  33. Villiger PM, Caliezi G, Cottin V, Förger F, Senn A, Østensen M. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010; 69:1842–1844

    Article  CAS  PubMed  Google Scholar 

  34. Weisenseel P, Prinz JC. Psoriasis vulgaris und Komorbiditäten. Dtsch Med Wochenschr 2010; 135: 1446–1450

    Article  CAS  PubMed  Google Scholar 

  35. Wylie G, Evans CD, Gupta G. Reduced libido and erectile dysfunction: rarely reported side-effects on methotrexat. J Dermatol 2006; 33:772–778

    Article  Google Scholar 

  36. Zitzmann M. Testosteron und metabolisches Syndrom. In: Krause W, Weidner W, Diemer T, Sperling H (eds.) Andrologie — Krankheiten der männlichen Geschlechtsorgane (4. Auflage). Georg Thieme Verlag, Stuttgart, 257–261, 2011

    Google Scholar 

  37. Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta-Analysis. J Invest Dermatol. 2013 Nov 27. doi: 10.1038/jid.2013.508. [Epub ahead of print]

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans-Christian Schuppe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuppe, HC., Jung, A., Ochsendorf, F.R. et al. Andrologische Aspekte im Auge haben!. hautnah dermatologie 30, 39–46 (2014). https://doi.org/10.1007/s15012-014-1747-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-014-1747-y

Navigation